Chemical Inhibition of JAK2 Mimics Genetic Ablation of Uterine Function of Leukemia Inhibitory Factor

Authors

  • Jrgang Cheng

Keywords:

leukemia inhibitory factor (LIF), implantation, janus kinase 2 (Jak2), tyrphostin, AG490, DMSO, signal transduction, contraception

Abstract

Uterine receptivity needs to be synchronized with embryonic development so the blastocyst stage of the embryo can implant Leukemia Inhibitory Factor LIF is an essential factor for implantation which is involved in the initiation of the window of implantation However the process by which the LIF signal pathway is transduced in the uterine luminal epithelium LE that leads to uterine receptivity is not completely elucidated We tested the ability of cellular signaling inhibitors to disrupt uterine support of the embryo Only Tyrphostin-AG490 an inhibitor of Jak2 can interfere with LIF signaling Not only can AG490 reduce phosphorylated STAT3 levels in isolated LE but it also ablated implantation when injected into uterine lumen Furthermore AG490 treatment in wild-type animals mimics the consequences of genetic ablation of LIF that results in free floating hatched embryos which are unable to implant Our results support the notion that Jak2 is the sole Janus kinase to mediate LIF activation in LE and the signaling pathways of cytokines can serve as contraception targets

How to Cite

Jrgang Cheng. (2016). Chemical Inhibition of JAK2 Mimics Genetic Ablation of Uterine Function of Leukemia Inhibitory Factor. Global Journal of Medical Research, 16(K2), 13–20. Retrieved from https://medicalresearchjournal.org/index.php/GJMR/article/view/1170

Chemical Inhibition of JAK2 Mimics Genetic Ablation of Uterine Function of Leukemia Inhibitory Factor

Published

2016-01-15